Cargando…

First-in-human use of (11)C-CPPC with positron emission tomography for imaging the macrophage colony-stimulating factor 1 receptor

PURPOSE: Study of the contribution of microglia to onset and course of several neuropsychiatric conditions is challenged by the fact that these resident immune cells often take on different phenotypes and functions outside the living brain. Imaging microglia with radiotracers developed for use with...

Descripción completa

Detalles Bibliográficos
Autores principales: Coughlin, Jennifer M., Du, Yong, Lesniak, Wojciech G., Harrington, Courtney K., Brosnan, Mary Katherine, O’Toole, Riley, Zandi, Adeline, Sweeney, Shannon Eileen, Abdallah, Rehab, Wu, Yunkou, Holt, Daniel P., Hall, Andrew W., Dannals, Robert F., Solnes, Lilja, Horti, Andrew G., Pomper, Martin G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9522955/
https://www.ncbi.nlm.nih.gov/pubmed/36175737
http://dx.doi.org/10.1186/s13550-022-00929-4
_version_ 1784800164050894848
author Coughlin, Jennifer M.
Du, Yong
Lesniak, Wojciech G.
Harrington, Courtney K.
Brosnan, Mary Katherine
O’Toole, Riley
Zandi, Adeline
Sweeney, Shannon Eileen
Abdallah, Rehab
Wu, Yunkou
Holt, Daniel P.
Hall, Andrew W.
Dannals, Robert F.
Solnes, Lilja
Horti, Andrew G.
Pomper, Martin G.
author_facet Coughlin, Jennifer M.
Du, Yong
Lesniak, Wojciech G.
Harrington, Courtney K.
Brosnan, Mary Katherine
O’Toole, Riley
Zandi, Adeline
Sweeney, Shannon Eileen
Abdallah, Rehab
Wu, Yunkou
Holt, Daniel P.
Hall, Andrew W.
Dannals, Robert F.
Solnes, Lilja
Horti, Andrew G.
Pomper, Martin G.
author_sort Coughlin, Jennifer M.
collection PubMed
description PURPOSE: Study of the contribution of microglia to onset and course of several neuropsychiatric conditions is challenged by the fact that these resident immune cells often take on different phenotypes and functions outside the living brain. Imaging microglia with radiotracers developed for use with positron emission tomography (PET) allows researchers to study these cells in their native tissue microenvironment. However, many relevant microglial imaging targets such as the 18 kDa translocator protein are also expressed on non-microglial cells, which can complicate the interpretation of PET findings. (11)C-CPPC was developed to image the macrophage colony-stimulating factor 1 receptor, a target that is expressed largely by microglia relative to other cell types in the brain. Our prior work with (11)C-CPPC demonstrated its high, specific uptake in brains of rodents and nonhuman primates with neuroinflammation, which supports the current first-in-human evaluation of its pharmacokinetic behavior in the brains of healthy individuals. METHODS: Eight healthy nonsmoker adults completed a 90-min dynamic PET scan that began with bolus injection of (11)C-CPPC. Arterial blood sampling was collected in order to generate a metabolite-corrected arterial input function. Tissue time-activity curves (TACs) were generated using regions of interest identified from co-registered magnetic resonance imaging data. One- and two-tissue compartmental models (1TCM and 2TCM) as well as Logan graphical analysis were compared. RESULTS: Cortical and subcortical tissue TACs peaked by 37.5 min post-injection of (11)C-CPPC and then declined. The 1TCM was preferred. Total distribution volume (V(T)) values computed from 1TCM aligned well with those from Logan graphical analysis (t* = 30), with V(T) values relatively high in thalamus, striatum, and most cortical regions, and with relatively lower V(T) in hippocampus, total white matter, and cerebellar cortex. CONCLUSION: Our results extend support for the use of (11)C-CPPC with PET to study microglia in the human brain. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13550-022-00929-4.
format Online
Article
Text
id pubmed-9522955
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-95229552022-10-01 First-in-human use of (11)C-CPPC with positron emission tomography for imaging the macrophage colony-stimulating factor 1 receptor Coughlin, Jennifer M. Du, Yong Lesniak, Wojciech G. Harrington, Courtney K. Brosnan, Mary Katherine O’Toole, Riley Zandi, Adeline Sweeney, Shannon Eileen Abdallah, Rehab Wu, Yunkou Holt, Daniel P. Hall, Andrew W. Dannals, Robert F. Solnes, Lilja Horti, Andrew G. Pomper, Martin G. EJNMMI Res Original Research PURPOSE: Study of the contribution of microglia to onset and course of several neuropsychiatric conditions is challenged by the fact that these resident immune cells often take on different phenotypes and functions outside the living brain. Imaging microglia with radiotracers developed for use with positron emission tomography (PET) allows researchers to study these cells in their native tissue microenvironment. However, many relevant microglial imaging targets such as the 18 kDa translocator protein are also expressed on non-microglial cells, which can complicate the interpretation of PET findings. (11)C-CPPC was developed to image the macrophage colony-stimulating factor 1 receptor, a target that is expressed largely by microglia relative to other cell types in the brain. Our prior work with (11)C-CPPC demonstrated its high, specific uptake in brains of rodents and nonhuman primates with neuroinflammation, which supports the current first-in-human evaluation of its pharmacokinetic behavior in the brains of healthy individuals. METHODS: Eight healthy nonsmoker adults completed a 90-min dynamic PET scan that began with bolus injection of (11)C-CPPC. Arterial blood sampling was collected in order to generate a metabolite-corrected arterial input function. Tissue time-activity curves (TACs) were generated using regions of interest identified from co-registered magnetic resonance imaging data. One- and two-tissue compartmental models (1TCM and 2TCM) as well as Logan graphical analysis were compared. RESULTS: Cortical and subcortical tissue TACs peaked by 37.5 min post-injection of (11)C-CPPC and then declined. The 1TCM was preferred. Total distribution volume (V(T)) values computed from 1TCM aligned well with those from Logan graphical analysis (t* = 30), with V(T) values relatively high in thalamus, striatum, and most cortical regions, and with relatively lower V(T) in hippocampus, total white matter, and cerebellar cortex. CONCLUSION: Our results extend support for the use of (11)C-CPPC with PET to study microglia in the human brain. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13550-022-00929-4. Springer Berlin Heidelberg 2022-09-30 /pmc/articles/PMC9522955/ /pubmed/36175737 http://dx.doi.org/10.1186/s13550-022-00929-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Research
Coughlin, Jennifer M.
Du, Yong
Lesniak, Wojciech G.
Harrington, Courtney K.
Brosnan, Mary Katherine
O’Toole, Riley
Zandi, Adeline
Sweeney, Shannon Eileen
Abdallah, Rehab
Wu, Yunkou
Holt, Daniel P.
Hall, Andrew W.
Dannals, Robert F.
Solnes, Lilja
Horti, Andrew G.
Pomper, Martin G.
First-in-human use of (11)C-CPPC with positron emission tomography for imaging the macrophage colony-stimulating factor 1 receptor
title First-in-human use of (11)C-CPPC with positron emission tomography for imaging the macrophage colony-stimulating factor 1 receptor
title_full First-in-human use of (11)C-CPPC with positron emission tomography for imaging the macrophage colony-stimulating factor 1 receptor
title_fullStr First-in-human use of (11)C-CPPC with positron emission tomography for imaging the macrophage colony-stimulating factor 1 receptor
title_full_unstemmed First-in-human use of (11)C-CPPC with positron emission tomography for imaging the macrophage colony-stimulating factor 1 receptor
title_short First-in-human use of (11)C-CPPC with positron emission tomography for imaging the macrophage colony-stimulating factor 1 receptor
title_sort first-in-human use of (11)c-cppc with positron emission tomography for imaging the macrophage colony-stimulating factor 1 receptor
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9522955/
https://www.ncbi.nlm.nih.gov/pubmed/36175737
http://dx.doi.org/10.1186/s13550-022-00929-4
work_keys_str_mv AT coughlinjenniferm firstinhumanuseof11ccppcwithpositronemissiontomographyforimagingthemacrophagecolonystimulatingfactor1receptor
AT duyong firstinhumanuseof11ccppcwithpositronemissiontomographyforimagingthemacrophagecolonystimulatingfactor1receptor
AT lesniakwojciechg firstinhumanuseof11ccppcwithpositronemissiontomographyforimagingthemacrophagecolonystimulatingfactor1receptor
AT harringtoncourtneyk firstinhumanuseof11ccppcwithpositronemissiontomographyforimagingthemacrophagecolonystimulatingfactor1receptor
AT brosnanmarykatherine firstinhumanuseof11ccppcwithpositronemissiontomographyforimagingthemacrophagecolonystimulatingfactor1receptor
AT otooleriley firstinhumanuseof11ccppcwithpositronemissiontomographyforimagingthemacrophagecolonystimulatingfactor1receptor
AT zandiadeline firstinhumanuseof11ccppcwithpositronemissiontomographyforimagingthemacrophagecolonystimulatingfactor1receptor
AT sweeneyshannoneileen firstinhumanuseof11ccppcwithpositronemissiontomographyforimagingthemacrophagecolonystimulatingfactor1receptor
AT abdallahrehab firstinhumanuseof11ccppcwithpositronemissiontomographyforimagingthemacrophagecolonystimulatingfactor1receptor
AT wuyunkou firstinhumanuseof11ccppcwithpositronemissiontomographyforimagingthemacrophagecolonystimulatingfactor1receptor
AT holtdanielp firstinhumanuseof11ccppcwithpositronemissiontomographyforimagingthemacrophagecolonystimulatingfactor1receptor
AT hallandreww firstinhumanuseof11ccppcwithpositronemissiontomographyforimagingthemacrophagecolonystimulatingfactor1receptor
AT dannalsrobertf firstinhumanuseof11ccppcwithpositronemissiontomographyforimagingthemacrophagecolonystimulatingfactor1receptor
AT solneslilja firstinhumanuseof11ccppcwithpositronemissiontomographyforimagingthemacrophagecolonystimulatingfactor1receptor
AT hortiandrewg firstinhumanuseof11ccppcwithpositronemissiontomographyforimagingthemacrophagecolonystimulatingfactor1receptor
AT pompermarting firstinhumanuseof11ccppcwithpositronemissiontomographyforimagingthemacrophagecolonystimulatingfactor1receptor